MetLife (MET)
Financials · Life & Health Insurance · NYSE
A global leader in insurance and employee benefits with a major institutional asset management platform and diversified international footprint.
What MetLife does
MetLife is a leading global provider of insurance, annuities, employee benefits, and asset management services. The company serves individuals and institutions, including large corporations and government entities, across the United States, Asia, Latin America, Europe, and the Middle East. It also operates a significant institutional asset management business, MetLife Investment Management, which oversees a large general account portfolio of fixed income securities and real estate.
Themes: employee benefits, retirement income solutions, asset management, global insurance expansion, institutional investment portfolio management
Fundamentals
- Price$94.34 as of 2026-08-21 close
- Market cap$60.0B as of 2026-08-21
- 1-year return+19.1% 2025-08-21 close $79.24 → 2026-08-21 close $94.34
- P/E17.07 as of 2026-08-24
- Net margin+4.6% as of 2026-08-24
- ROE+12.9% as of 2026-08-24
- Debt / equity0.72 as of 2026-08-24
- Revenue growth (YoY)+8.4% as of 2026-08-24
- Revenue CAGR (3y)+3.9% SEC XBRL
- Beta0.78 as of 2026-08-24
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +3.3%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How MET compares in its sector
- price-to-earnings ratiomiddle range 525 covered Financials peers, as of 2026-08-24
- net profit marginbottom 25% 538 covered Financials peers, as of 2026-08-24
- operating marginbottom 25% 534 covered Financials peers, as of 2026-08-24
- return on equitymiddle range 575 covered Financials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 347 covered Financials peers
- indicated dividend yieldmiddle range 453 covered Financials peers, as of 2026-08-24
Position among covered Financials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
MET is not currently in any published Top 10 list. Its scores are below.
Long-term score
50.5 #476 of 987 scored · #156 of 191 in Financials
Capital return 71st (consecutive years of dividend increases 5 years) and financial health 62nd (free cash flow margin 19.6%, debt to equity 0.7); weakest is profitability (33rd, operating margin 7.4%, return on equity 12.9%).
Short-term score
62.8 #102 of 1,704 scored · #22 of 277 in Financials
Volume and participation 92nd: trading volume is about normal versus its 30-day average; catalysts 71st: open-market insider buys in 90 days 21, analysts have raised their average price target by 0.7% since the prior reading; weakest is trend 42nd: a trend forming but not yet strong (ADX below 25).
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, MET's dividend was covered by reported results (earnings payout 45%, operating-cash-flow payout 9%). This describes past coverage, not a forecast.
- Earnings payout45% dividends / net income
- Operating-cash-flow payout9% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How MetLife looks technically
MetLife (MET) is trading 16.6% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 50 trading days ago — a "golden cross", a bullish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 12 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 2% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 16.6% above its 200-day average, the long-term trend line — a longer-term uptrend | +16.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $92.34 | $92.34 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $80.89 | $80.89 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 89.44. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible upward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 50 trading days ago — a "golden cross", a bullish long-term signal | 50 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend) | 24.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30) | 47.6 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($93.38 to $100.93) — its "stochastic" reading is 13 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 12.7 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 11 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $100.93 | $100.93 |
|---|---|---|
| From the 52-week high | it is 6.5% below its 52-week high (its highest price of the past year) | -6.5% |
| Above the 52-week low | it is 40.1% above its 52-week low (its lowest price of the past year) | +40.1% |
| Below the 52-week high | it is 6.5% below its highest point of the past year | 6.5% |
| Since a 20-day breakout | it made a new 20-day high about 12 trading days ago | 12 sessions |
| Since a 55-day breakout | it made a new 55-day high about 12 trading days ago | 12 sessions |
| All-time high | its highest closing price on record is $100.93 (set on 2026-08-06) | $100.93 |
| Given back of the 52-week move | over the past year its closes ranged ($67.70 to $99.95), and it has given back roughly a quarter of its rise from last year’s low — 17% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $78.99 to $80.02. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 17.4% |
| From the all-time high | it is 6.5% below its all-time high | -6.5% |
| Nearest price level | it is trading 5.4% above a support level at $89.25 — a price it turned at twice since 2024-11-27, most recently on 2026-06-12. Since 2024-08-21 it has 9 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -5.4% |
| All-time low | its lowest closing price on record is $10.13 (set on 2009-03-06) | $10.13 |
| Above the all-time low | it is 831.0% above its all-time low | +831.0% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 2% of the past ~6 months), which often precedes a bigger move | 2nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.78 between its high and its low — about 1.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.78 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $93.89 and $99.24 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $93.89 – $96.56 – $99.24 |
| Typical daily range (% of price) | its price moves about 1.9% in a typical session — among the calmest in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 1.9% |
| Stretch from the 200-day average | it is trading 7.5 daily ranges above its 200-day average price (16.6% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 7.5 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.44× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.7% since the prior reading | +0.7% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 5 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 5 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.8% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +0.8% |
|---|---|---|
| Gap filled | a 2.4% gap up opened on 2026-08-06 has been "filled" 2 sessions ago — price traded back through the level the gap left behind, and it took 9 sessions to close | 2 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 1.3 percentage points (the stock gained 1.0% while the market gained 2.3%) | -1.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 8.8 percentage points (the stock gained 11.9% while the market gained 3.1%) | +8.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 8.2 percentage points (the stock gained 19.3% while the market gained 11.1%) | +8.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 1.4 percentage points (the stock gained 19.1% while the market gained 20.5%) | -1.4% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, near the bottom of its 14-day range (oversold), trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 4.9% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 4.8% of the share price. | +4.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 16% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $81.64 — a volume-weighted average of daily closes over 156 sessions, not a true tick-by-tick VWAP. | +15.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% below the average price paid since it last reported on 2026-08-05 (its 8-K), so the typical buyer over that stretch is under water. That average is $96.50 — a volume-weighted average of daily closes over 13 sessions, not a true tick-by-tick VWAP. | -2.2% |
Price levels it has turned at before
MET last closed at $94.34 on 2026-08-21. Since 2024-08-21 it has turned at 9 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $89.25 | Support | 5.4% below the last close | turned there twice · 2024-11-27 to 2026-06-12 |
| $87.47 | Support | 7.3% below the last close | turned there three times · 2024-10-15 to 2025-03-03 |
| $84.33 | Support | 10.6% below the last close | turned there six times · 2025-01-06 to 2026-06-24 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $89.44.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $92.56 and $96.98 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close above $100.93.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · in a Bollinger Band volatility squeeze · beating the market · Least volatile (2% or less typical daily range) · Stretched far above its 200-day average (6+ daily ranges) · At the bottom of its 14-day range (stochastic below 20) | Learn: moving average · golden cross · adx · rsi · breakout · bollinger bands
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.94 mean, 1=Strong Buy…5=Strong Sell) — 16 analysts
- Mean price target$104.38 range $84.00 – $119.00; median $105.00
Analyst estimates, as of 2026-08-22. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for MET
- Consensus EPS estimate$2.57 next reporting period, as of 2026-08-22
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Sensitivity to interest rate fluctuations, credit spreads, and equity market volatility.","Potential for large-scale claims due to catastrophes or public health events.","Risks associated with the management of fixed income portfolios and real estate investments."]
What changed in the latest 10-Q
AI-assisted comparison of MET's 10-Q filed 2026-05-07 against the prior one filed 2025-11-07.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-07) includes new Business Overview section describing Strategic Reorganization in Q4 2025, reorganization of segment structure, and creation of MetLife Investment Management (MIM) as reportable segment
- Newer filing references 2025 Annual Report (Form 10-K for year ended December 31, 2025) instead of 2024 Annual Report
- Newer filing adds reference to 'value of our assets under management (AUM)' in Financial and Economic Environment section
- Newer filing includes new paragraph in Impact of Market Interest Rates section discussing institutional asset management business and AUM fee impacts
- Newer filing adds expanded Competitive Pressures section with multiple cross-references to Business sections and Risk Factors
- Newer filing includes discussion of interest rate actions in 2025 (second half rate lowering and end of quantitative tightening) and reference to rates remaining steady in 2026
- Removed:
- Older filing (2025-11-07) included 'Business Overview & Strategy' as separate index item; newer filing separates into 'Business Overview' only
- Older filing included 'Subsequent Events' in index; newer filing does not
- Older filing reference to 'Federal Open Market Committee recently cut interest rates' replaced with more detailed 2025 actions in newer filing
- Older filing's reference to 'U.S. government shutdown' as potential policy adjustment factor removed in newer filing
- Older filing's brief reference to Competitive Pressures removed and replaced with expanded detailed section in newer filing
- Older filing's detailed discussion of negative IMR and PBR regulatory matters not present in excerpt of newer filing
- Reworded:
- Older: 'Federal Open Market Committee recently cut interest rates'; Newer: 'Federal Open Market Committee took various actions in 2025 to promote employment and combat inflation, including lowering interest rates in the second half of the year and ending the process of quantitative tightening'
- Older: 'Other central banks have recently held rates steady but are signaling caution'; Newer: 'Other central banks have recently diverged on monetary policies, reflecting differing local economic conditions'
- Older references 'investment portfolio and derivatives'; Newer adds 'value of our assets under management (AUM)' to this list
- Older: Impact of Market Interest Rates section refers generally to 'business and investments'; Newer specifies 'In our institutional asset management business' with detailed discussion of AUM and fee impacts
- Newer filing adds: 'While rates have remained steady in 2026, labor market conditions, inflation, and financial and international developments, as well as other factors, could result in policy adjustments later this year'
- Notes:
- Older filing excerpt appears truncated at regulatory developments section; comparison limited to available text
- Index page numbers differ between filings due to different document lengths and formatting
- Strategic Reorganization is new disclosure in 2026 Q1 filing reflecting Q4 2025 corporate action
Risk Factors
- Added:
- In factor (1), newer filing adds 'changes in the value of assets under management,' as a specific economic risk factor (filed 2026-05-07)
- Removed:
- In factor (10), older filing reference to 'environmental, social, and governance standards' removed; newer filing uses only 'sustainability standards' (filed 2025-11-07)
- Reworded:
- Factor (1): Older filing lists 'real estate, obligors and counterparties' as separate items; newer filing restructures to 'changes in the value of assets under management, real estate, obligors and counterparties' (filed 2026-05-07)
- Factor (10): Changed from 'unsuccessful efforts to meet all environmental, social, and governance standards or to enhance our sustainability' to 'unsuccessful efforts to meet all sustainability standards or to enhance our sustainability' (filed 2026-05-07)
- Notes:
- The two filings cover different periods (Q1 2026 vs. Q3 2025) and contain financial statements with different dates, but the Risk Factors forward-looking statements section shows minimal substantive changes
- Page number changes observed (Item 1A Risk Factors on page 139 in newer vs. page 161 in older) reflect document formatting differences, not content changes to risk factors themselves
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days.
- Last 90 days0 buys · 1 sell ($2M) — 1 selling insider
- Last 180 days0 buys · 1 sell ($2M) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-06-01. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about MET's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for MET from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding MET as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 82,608,890
- Reported value $5,842,100,716
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 1 increased, 5 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
MET had 11,289,925 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
MET had 1.78% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.56 days to cover at the same settlement.
- Reported short interest (shares) 11,289,925
- Short interest (% of shares outstanding) 1.78%
- Prior settlement (shares) 12,774,912
- Reported change -11.62%
- Days to cover (reported) 2.56
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Prudential Financial (PRU)
- Aflac (AFL)
- Lincoln National (LNC)
- Principal Financial Group (PFG)
- Manulife Financial (MFC)
- AIG (AIG)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare MET vs…
MetLife is found in…
Frequently asked questions
What does MetLife (MET) do?
MetLife is a leading global provider of insurance, annuities, employee benefits, and asset management services. The company serves individuals and institutions, including large corporations and government entities, across the United States, Asia, Latin America, Europe, and the Middle East. It also operates a significant institutional asset management business, MetLife Investment Management, which oversees a large general account portfolio of fixed income securities and real estate.
What sector is MetLife (MET) in?
MetLife (MET) is classified in the Financials sector. Its industry is Life & Health Insurance. It trades on NYSE.
Does MET pay a dividend?
Yes — MetLife (MET) pays a dividend, with an indicated yield of about 3.27% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are MetLife's (MET) competitors?
Notable peers of MetLife (MET) include Prudential Financial, Aflac, Lincoln National, Principal Financial Group and Manulife Financial. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in MET?
Yes — we hold 2 matched STOCK Act disclosures for MET from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is MetLife (MET) overbought or oversold right now?
MetLife (MET) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 48, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on MET come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.